These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 39162245
1. Salivary Gland Neoplasm of Uncertain Malignant Potential (SUMP) (Milan IVB) and Its Subgroups: A Multi-Institutional Analysis of Risk of Neoplasm and Malignancy. Xia R, Hindi I, Savant D, Khader S, Lajara S, Belovarac B, Das K, Chau K, Abdelwahed M, Ali A, Szeto O, Hernandez O, Sun W, Liu CZ, Zhou F, Simsir A, Brandler TC. Diagn Cytopathol; 2024 Dec; 52(12):756-762. PubMed ID: 39162245 [Abstract] [Full Text] [Related]
2. Risk of malignancy associated with cytomorphology subtypes in the salivary gland neoplasm of uncertain malignant potential (SUMP) category in the Milan System: A bi-institutional study. Chowsilpa S, An D, Lose H, Huang X, Nayar R, Maleki Z. Cancer Cytopathol; 2019 Jun; 127(6):377-389. PubMed ID: 31116514 [Abstract] [Full Text] [Related]
5. Multi-institutional validation of a modified scheme for subcategorizing salivary gland neoplasm of uncertain malignant potential (SUMP). Hang JF, Lee JJL, Nga ME, Higuchi K, Hirata Y, Wu HH, Allison DB, Gilbert JD, Lin O, Saieg M, de Arruda AF, Chen YA, Huang EC, Manucha V. Cancer Cytopathol; 2022 Jul; 130(7):511-522. PubMed ID: 35637575 [Abstract] [Full Text] [Related]
6. Analysis of the risk of malignancy associated with the basaloid and oncocytic subtypes of the salivary gland neoplasm of unknown malignant potential (SUMP) category in the Milan system. Manucha V, Gonzalez MF, Akhtar I. Cancer Cytopathol; 2021 Aug; 129(8):603-611. PubMed ID: 33788998 [Abstract] [Full Text] [Related]
7. Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study. Maleki Z, Baloch Z, Lu R, Shafique K, Song SJ, Viswanathan K, Rao RA, Lefler H, Fatima A, Wiles A, Jo VY, Wang H, Fadda G, Powers CN, Ali SZ, Pantanowitz L, Siddiqui MT, Nayar R, Klijanienko J, Barkan GA, Krane JF, Rossi ED, Callegari F, Kholová I, Bongiovanni M, Faquin WC, Pusztaszeri MP. Cancer Cytopathol; 2019 May; 127(5):306-315. PubMed ID: 31050186 [Abstract] [Full Text] [Related]
8. Utility of the Milan System for Reporting Salivary Gland Cytology, with focus on the incidence and histologic correlates of atypia of undetermined significance (AUS) and salivary gland neoplasm of uncertain malignant potential (SUMP): A 3-year institutional experience. Cormier CM, Agarwal S. Cancer Cytopathol; 2022 Apr; 130(4):303-312. PubMed ID: 34875145 [Abstract] [Full Text] [Related]
9. Application of the Milan System for Reporting Salivary Gland Cytopathology in pediatric patients: An international, multi-institutional study. Maleki Z, Saoud C, Viswanathan K, Kilic I, Tommola E, Griffin DT, Heider A, Petrone G, Jo VY, Centeno BA, Saieg M, Mikou P, Fadda G, Ali SZ, Kholová I, Wojcik EM, Barkan GA, Eisele DW, Bellevicine C, Vigliar E, Wiles AB, Al-Ibraheemi A, Allison DB, Dixon GR, Chandra A, Walsh JM, Baloch ZW, Faquin WC, Krane JF, Rossi ED, Pantanowitz L, Troncone G, Callegari FM, Klijanienko J. Cancer Cytopathol; 2022 May; 130(5):370-380. PubMed ID: 35081269 [Abstract] [Full Text] [Related]
10. Application of the Milan System for Reporting Salivary Gland Cytopathology to cystic salivary gland lesions. Maleki Z, Allison DB, Butcher M, Kawamoto S, Eisele DW, Pantanowitz L. Cancer Cytopathol; 2021 Mar; 129(3):214-225. PubMed ID: 33002347 [Abstract] [Full Text] [Related]
11. The role of the Milan System for Reporting Salivary Gland Cytopathology: A 5-year institutional experience. Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. Cancer Cytopathol; 2018 Aug; 126(8):541-551. PubMed ID: 29797690 [Abstract] [Full Text] [Related]
13. Mucoepidermoid carcinoma, acinic cell carcinoma, and adenoid cystic carcinoma on fine-needle aspiration biopsy and The Milan System: an international multi-institutional study. Miller JA, An D, Shafique K, Song S, Rao RA, Viswanathan K, Eykman E, Wiles A, Ali SZ, Field A, Fadda G, Barkan GA, Layfield LJ, Rossi ED, Powers CN, Siddiqui MT, Kholova I, Baloch Z, Maleki Z. J Am Soc Cytopathol; 2019 Aug; 8(5):270-277. PubMed ID: 31104944 [Abstract] [Full Text] [Related]
15. Application of the Milan System for Reporting Salivary Gland Cytopathology: A Retrospective 12-Year Bi-institutional Study. Wu HH, Alruwaii F, Zeng BR, Cramer HM, Lai CR, Hang JF. Am J Clin Pathol; 2019 May 03; 151(6):613-621. PubMed ID: 30852595 [Abstract] [Full Text] [Related]
16. Northern Italy in the American South: Assessing interobserver reliability within the Milan System for Reporting Salivary Gland Cytopathology. Hollyfield JM, O'Connor SM, Maygarden SJ, Greene KG, Scanga LR, Tang S, Dodd LG, Wobker SE. Cancer Cytopathol; 2018 Jun 03; 126(6):390-396. PubMed ID: 29579353 [Abstract] [Full Text] [Related]
17. Retrospective implementation of the Milan system for reporting salivary gland cytopathology; a review of 5 years in a specialized cancer center. Jaber OI, Shawash SI. Diagn Cytopathol; 2021 Feb 03; 49(2):187-194. PubMed ID: 33002325 [Abstract] [Full Text] [Related]
18. A Retrospective Cytomorphologic Analysis of Salivary Gland Fine Needle Aspirates Classified as Salivary Gland Neoplasm of Uncertain Malignant Potential: A 6-year Institutional Experience. Agarwal S. Diagn Cytopathol; 2024 Dec 03; 52(12):738-746. PubMed ID: 39140360 [Abstract] [Full Text] [Related]
20. Salivary gland fine-needle aspiration cytology with the application of the Milan system for risk stratification and histological correlation: A retrospective 6-year study. Rivera Rolon M, Schnadig VJ, Faiz S, Nawgiri R, Clement CG. Diagn Cytopathol; 2020 Nov 03; 48(11):1067-1074. PubMed ID: 32452653 [Abstract] [Full Text] [Related] Page: [Next] [New Search]